Cited by 165Sleep and related disordersSleep and Wakefulness ResearchRestless Legs Syndrome Research

The DOI matches its Crossref record; 258 of the 258 references it cites were found in a registry or an index.

Parasomnias: An Updated Review

Open access
Howell, Michael J.·2012·Neurotherapeutics

Abstract

Parasomnias are abnormal behaviors emanating from or associated with sleep. Sleepwalking and related disorders result from an incomplete dissociation of wakefulness from nonrapid eye movement (NREM) sleep. Conditions that provoke repeated cortical arousals, or promote sleep inertia lead to NREM parasomnias by impairing normal arousal mechanisms. Changes in the cyclic alternating pattern, a biomarker of arousal instability in NREM sleep, are noted in sleepwalking disorders. Sleep-related eating disorder (SRED) is characterized by a disruption of the nocturnal fast with episodes of feeding after an arousal from sleep. SRED is often associated with the use of sedative-hypnotic medications; in particular, the widely prescribed benzodiazepine receptor agonists. Recently, compelling evidence suggests that nocturnal eating may in some cases be a nonmotor manifestation of Restless Legs Syndrome (RLS). rapid eye movement (REM) Sleep Behavior Disorder (RBD) is characterized by a loss of REM paralysis leading to potentially injurious dream enactment. The loss of atonia in RBD often predates the development of Parkinson's disease and other disorders of synuclein pathology. Parasomnia behaviors are related to an activation (in NREM parasomnias) or a disinhibition (in RBD) of central pattern generators (CPGs). Initial management should focus on decreasing the potential for sleep-related injury followed by treating comorbid sleep disorders. Clonazepam and melatonin appear to be effective therapies in RBD, whereas paroxetine has been reported effective in some cases of sleep terrors. At this point, pharmacotherapy for other parasomnias is less certain, and further investigations are necessary.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s13311-012-0143-8

Cites

258 of 258 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 258 references

Research works printed but not linked: 4

  1. Schenck, 2005, Zolpidem-induced Sleep-Related Eating Disorder (SRED) in 19 patients, Sleep, 28, a259
  2. Schenck, 1992, Does REM sleep behavior disorder protect against obstructive sleep apnea?, REM sleep behavior disorder protect against obstructive sleep apnea, 21, 21257
  3. Arkin, 1978, Night-Terrors as Anomalous REM sleep component manifestation in slow-wave sleep, Waking Sleeping, 2, 143
  4. Schenck, 2006, Topiramate therapy of sleep related eating disorder (SRED), Sleep, 29, a268

Cited by

Sorted by citations

See all 165

Metadata

Authors
Howell, M. J.
Affiliations
University of Minnesota (US)
Corresponding author
Howell, Michael J.
Venue
Neurotherapeutics
Publisher
Elsevier BV
Published
2012-10
Volume
9
Issue
4
Pages
753-775
ISSN
1878-7479 (ISSN-L)
OpenAlex
W2078251421
Cited by
165
References
258
Citations by year
2026: 17 · 2025: 4 · 2024: 8 · 2023: 15 · 2022: 17 · 2021: 14 · 2020: 15 · 2019: 13 · 2018: 12 · 2017: 10 · 2016: 18 · 2015: 6 · 2014: 6 · 2013: 5 · 2012: 3
FWCI
0.94
Type
journal article
Language
en
Open access
Locations
  • Neurotherapeutics (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
  • Health Sciences › Medicine › Clinical Neurology › Restless Legs Syndrome Research
Keywords
parasomnias, sleepwalking, sleep-related eating disorder, REM sleep behavior disorder, restless legs syndrome, sleep inertia, cyclic alternating pattern, benzodiazepine receptor agonists, clonazepam, melatonin, paroxetine, central pattern generator, synucleinopathies, Parkinson's disease, sleep disorders comorbidity
MeSH terms
Humans, Parasomnias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review